India's drug regulator has approved Itolizumab, a drug used to cure skin ailment psoriasis for "restricted emergency use" to treat COVID-19 patients with moderate to severe acute respiratory distress,...
from NDTV News - Latest https://ift.tt/3iU2Gg6
Saturday, July 11, 2020
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment